for Neurizon’s lead drug candidate NUZ-001 – for the treatment of amyotrophic lateral sclerosis (ALS), also known as motor neurone disease. An OMPD provides a robust framework of benefits ...
We’re thrilled to share that Neuron’s entire software stack is now fully open-source under the MIT license. Anyone can freely access, modify, and build upon our code. This decision was made to foster ...
NUZ-001 shows encouraging results in slowing disease progression and increasing life expectancy of patients with ALS Patients are now in their 27th month of continuous treatment with NUZ-001, with ...
This important study identifies neurotrophin signaling as a molecular mechanism underlying previous findings of structural plasticity in central dopaminergic neurons of the adult fly brain. The ...
The offspring were removed from breeding cages on P2, P9, or P16 and were administered an overdose (200 mg/kg, i.p.) of pentobarbital (Millipore Sigma, Burlington, MA), or 5% isoflurane prior to ...
“It shows NUN-004 has the potential to provide a new therapeutic option for patients with motor neurone disease – not only in slowing disease progression but also improving gross and fine ...
A 'devoted and loving' husband and wife killed themselves in a suicide pact after she was diagnosed with motor neurone disease. Lynn Hunt said that she did not want to be fed with a tube ...
Concretely, an increase in BDNF erases all synaptic competition ... has shown that it can play an important role in establishing a global organization of synapses on the entire dendritic tree of the ...
A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queensland has produced successful results in a human clinical trial. NuNerve ...